Breast cancer is categorized into different subtypes based on the expression of various biomarkers, including estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki67. This evidence concerns the gene PGR and breast carcinoma.